Cytokines decrease expression of interleukin-6 signal transducer and leptin receptor in central nervous system glia.
Multiple sclerosis (MS) lesion formation is modulated by cytokines secreted within the central nervous system (CNS). Th1 lymphocytes and monocyte/macrophages (MM) likely induce lesion formation, whereas Th2 lymphocytes may inhibit formation. To explore the role of cytokines in MS lesions, we used gene arrays to investigate effects of cytokines representative of Th1 and Th2 cells and M/M on gene expression in cultured CNS glia; at 6 hr, all three increased expression of the interleukin-6 (IL-6) gene and decreased expression of the leptin receptor gene (obr), which mediates IL-6 production and other inflammatory responses. However, expression of a closely related gene, the interleukin-6 signal transducer or gp130 (IL-6st), showed no changes at 6 hr. IL-6st is an essential component of receptor complexes for IL-6 and other cytokines and growth factors that play critical roles in CNS inflammation, protection, and/or regeneration. To analyze expression of IL-6st and leptin receptor over time, we incubated rat CNS glial cultures for 6 hr to 5 days with the cytokines. All three cytokine mixtures down-regulated both IL-6st and leptin receptor mRNA and protein for up to 5 days. Immunocytochemical staining showed expression of both IL-6st and leptin receptor in all three types of glia, with lower IL-6st expression by 3 days. Down-regulation of IL-6st and leptin receptor in glia by cytokines could lead to decreased signaling by the proinflammatory IL-6 and reduced responses to regenerative/protective growth factors such as leukemia inhibitory factor and ciliary neurotrophic factor, potentially affecting the disease course in MS.
Rose
Jason J
JJ
Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
Bealmear
Beverly
B
Nedelkoska
Liljana
L
Studzinski
Diane
D
Lisak
Robert P
RP
Benjamins
Joyce A
JA
D000818:Animals; D000831:Animals, Newborn; D015153:Blotting, Western; D050822:Cytokine Receptor gp130 / Q000378:metabolism*; D016207:Cytokines / Q000276:immunology / Q000378:metabolism*; D015536:Down-Regulation; D015870:Gene Expression; D007150:Immunohistochemistry; D008264:Macrophages / Q000276:immunology; D009457:Neuroglia / Q000276:immunology / Q000378:metabolism*; D020411:Oligonucleotide Array Sequence Analysis; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D054411:Receptors, Leptin / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
D016207:Cytokines; D012333:RNA, Messenger; D054411:Receptors, Leptin; D050822:Cytokine Receptor gp130